← FDA Drug Approvals (Drugs@FDA)

ROMIDEPSIN

NDA · New Drug Application · Sponsor: TEVA PHARMS USA INC · Approved 2020-03-13

Drug application

FDA Application #

NDA208574

Application type

New Drug Application

Brand name

ROMIDEPSIN

Generic name

Romidepsin

Active ingredients

ROMIDEPSIN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

TEVA PHARMS USA INC

First approval

2020-03-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown